Skip to main content
. 2017 May 23;8(45):79376–79386. doi: 10.18632/oncotarget.18123

Table 1. The clinical features of patients and masses.

Variable Datum
No. of patients 122
With 1 mass ablated* 71 (58.2%)
With 2 masses ablated* 35 (28.7%)
With 3 masses ablated* 11(9.0%)
With 4 masses ablated* 3(2.5%)
With 6 masses ablated* 2(1.6%)
Mean age(y) 36.6±10.5 (17-74)
No. of masses 198
 ≤2 cm 156 (78.8%)
  >2 cm 42 (21.2%)
Mean mass diameter(cm) 1.6±0.7 (0.7-4.9)
Growth locations of masses
Adjacent to skin* 27 (14.4%)
Adjacent to pectoralis* 22 (11.8%)
Adjacent to areola*
In the parenchyma*
36 (19.3%)
102(54.5%)
Median ablation time(min)§ 3.2 (0.5-18.3)
Ablation power(W) 28.3±6.2(20-50)
Mean ablation insertions 1.2±0.4 (1-2)
Median follow-up(mo)§ 6.0 (4-26)

Note.—* Data in parentheses are percentages.

Data are means ± standard deviation; data in parentheses are ranges.

§Data in parentheses are ranges.